The Neurofibromatosis Network is delighted to bring you our new science column, The Network Edge, written by science writer Vanessa L. Merker, PhD, providing a summary of recent highlights from NF research and clinical trials. The Network, through advocacy on Capitol Hill and direct funding of research, plays a central role in progress toward a cure.
Every three months The Network Edge will bring you the latest research news as compiled by science writer, Vanessa L. Merker, PhD. The goal is to keep you abreast of advancements in treatment and clinical care for all forms of NF.
The Network Edge is presented in bite-sized pieces, allowing you to easily find and focus on those topics of most interest to you, whether it is NF1 learning disabilities studies, NF2 clinical trial updates or schwannomatosis news.